Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 6/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 5/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | CHRNA7 | P36544 | 4/20 | 0.51 |
| ▸ | BCHE | P06276 | 1/20 | 0.51 |
| ▸ | ACHE | P22303 | 1/20 | 0.51 |
| ▸ | GLA | P06280 | 1/20 | 0.51 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.49 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| (R)-Aceclidine SCHEMBL9146752 | 1.00 | CHRM2 (1.00) | CHRM2CHRM1MEN1CYP2D6KMT2A | |
| (S)-Aceclidine SCHEMBL9146471 | 1.00 | CHRM2 (1.00) | CHRM2CHRM1MEN1CYP2D6KMT2A | |
| Aceclidine SCHEMBL6237805 | 0.98 | CHRM2 (0.96) | CHRM2CHRM1MEN1CYP2D6KMT2A | |
| SCHEMBL10574679 | 0.90 | CHRM2 (0.82) | CHRM2CHRM1MEN1CYP2D6KMT2A | |
| SCHEMBL16933508 | 0.86 | CHRM2 (0.75) | CHRM2CHRM1MEN1CYP2D6KMT2A | |
| Oxalic Acid SCHEMBL10571388 | 0.85 | CHRM2 (0.74) | CHRM2CHRM1MEN1CYP2D6KMT2A | |
| SCHEMBL3743481 | 0.83 | CHRM2 (0.71) | CHRM2CHRM1MEN1CYP2D6KMT2A | |
| Aceclidine SCHEMBL4140116 | 0.83 | CHRM2 (0.69) | CHRM2CHRM1MEN1CYP2D6KMT2A | |
| Aceclidine SCHEMBL13724819 | 0.82 | CHRM2 (0.68) | CHRM2CHRM1MEN1CYP2D6KMT2A | |
| Aceclidine SCHEMBL28142116 | 0.82 | CHRM2 (0.68) | CHRM2CHRM1MEN1CYP2D6KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2027 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026107412-A1 | SARCOSPAN MODULATION AND METHODS OF MEAT AND TISSUE CULTURE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-05-21 | — | — | WO | claimed |
| EP-3310336-B1 | OPHTHALMOLOGICAL COMPOSITION COMPRISING ACECLIDINE AND MANNITOL FOR USE IN THE TREATMENT OF PRESBYOPIA | LENZ THERAPEUTICS OPERATIONS INC (US) | 2026-05-20 | — | — | EP | claimed |
| US-20260130896-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF OPHTHALMOLOGICAL ACTIVES | ADS THERAPEUTICS LLC (US) | 2026-05-14 | — | — | US | claimed |
| EP-4739312-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF OPHTHALMOLOGICAL ACTIVES | ADS Therapeutics LLC (US) | 2026-05-13 | — | — | EP | claimed |
| EP-4724079-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION | Stealth BioTherapeutics Inc. (US) | 2026-04-15 | — | — | EP | claimed |
| US-20260069533-A1 | METHODS FOR THE TREATMENT OF PRESBYOPIA | LENZ THERAPEUTICS OPERATIONS INC (US) | 2026-03-12 | — | — | US | claimed |
| US-20260053781-A1 | COMPOSITIONS, METHODS, AND SYSTEMS FOR TREATING PRESBYOPIA | LENZ THERAPEUTICS OPERATIONS INC (US) | 2026-02-26 | — | — | US | claimed |
| US-20260048096-A1 | METHODS AND COMPOSITIONS FOR PRESERVING THE RETINAL OUTER NUCLEAR LAYER (ONL), PHOTORECEPTORS, AND RETINAL THICKNESS | STEALTH BIOTHERAPEUTICS INC. (US) | 2026-02-19 | — | — | US | claimed |
| US-12533347-B2 | Compositions and methods for storage stable ophthalmic drugs | LENZ THERAPEUTICS OPERATIONS, INC. (US) | 2026-01-27 | — | — | US | claimed |
| EP-4658373-A1 | CRYSTALLINE ACECLIDINE HCL HEMIHYDRATE AND PROCESSES FOR PREPARING THE SAME | OLON S.p.A. (IT) | 2025-12-10 | — | — | EP | claimed |
| WO-2000064425-A2 | MIOTIC AGENTS AND HYPERTONIC AGENTS CONTAINING OPHTHALMIC COMPOSITIONS | FARMIGEA S.P.A. (IT) | 2000-11-02 | — | — | WO | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| WO-1997030701-A2 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF GLAUCOMA | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1997-08-28 | — | — | WO | claimed |
| US-5442053-A | Salts and mixtures of hyaluronic acid with pharmaceutically active substances, pharmaceutical compositions containing the same and methods for administration of such compositions | FIDIA, S.P.A. (IT) | 1995-08-15 | — | — | US | claimed |
| EP-0197718-B1 | New medicaments for topical use | FIDIA SPA (IT) | 1993-12-15 | — | — | EP | claimed |
| WO-1993018748-A1 | COMPOSITIONS COMPRISING A DRUG DELIVERY VEHICLE SUSPENDED IN A NONAQUEOUS FLUORINATED LIQUID | ALLERGAN, INC. (US) | 1993-09-30 | — | — | WO | claimed |
| EP-0550615-A1 | DRUG DELIVERY VEHICLES SUSPENDED IN NONAQUEOUS PERFLUORINATED CARRIER. | ALLERGAN INC (US) | 1993-07-14 | — | — | EP | claimed |
| WO-1992005770-A1 | DRUG DELIVERY VEHICLES SUSPENDED IN NONAQUEOUS PERFLUORINATED CARRIER | ALLERGAN, INC. (US) | 1992-04-16 | — | — | WO | claimed |
| US-4736024-A | Process for preparing salt of hyaluronic acid with a pharmaceutically active substance | FIDIA, S.P.A. (IT) | 1988-04-05 | — | — | US | claimed |
| EP-0197718-A2 | New medicaments for topical use | FIDIA S.p.A. (IT) | 1986-10-15 | — | — | EP | claimed |